Filing Details
- Accession Number:
- 0001209191-18-034231
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-30 18:02:53
- Reporting Period:
- 2018-05-30
- Accepted Time:
- 2018-05-30 18:02:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1689813 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1704255 | James Engelhart | C/O Biohaven Pharmaceuticals, Inc. 234 Church Street New Haven CT 06510 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2018-05-30 | 5,000 | $0.61 | 5,000 | No | 4 | M | Direct | |
Common Shares | Disposition | 2018-05-30 | 5,000 | $35.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Employee Stock Option (Right to Buy) | Disposition | 2018-05-30 | 5,000 | $0.00 | 5,000 | $0.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,500 | 2024-11-25 | No | 4 | M | Direct |
Footnotes
- These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Immediately exercisable.